Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey.

Burisch J Ailsa L Hart Andreas Sturm Christine Rudolph Rachael Meadows Anna Jus Fatima Dawod Haridarshan Patel Alessandro Armuzzi

Published in: Inflammatory bowel diseases (2024)

Patients with IBD, both in remission and not in remission, experience residual symptoms that impair HRQoL. Comprehensive endpoints, incorporating HRQoL and patients' perspectives, and improved treatments are needed to address residual disease and patients' needs.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patients with inflammatory bowel disease
rheumatoid arthritis
patient reported outcomes
risk factors